Page last updated: 2024-08-23

mifepristone and Alveolar Bone Atrophy

mifepristone has been researched along with Alveolar Bone Atrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Breivik, T; Gjermo, P; Gundersen, Y; Opstad, PK	1

Other Studies

1 other study(ies) available for mifepristone and Alveolar Bone Atrophy

Article	Year
Chronic treatment with the glucocorticoid receptor antagonist RU486 inhibits diabetes-induced enhancement of experimental periodontitis. Journal of periodontal research, 2014, Volume: 49, Issue:1 Topics: Alveolar Bone Loss; Animals; Blood Glucose; Body Weight; Corticosterone; Diabetes Mellitus, Experimental; Drug Implants; Escherichia coli; Hormone Antagonists; Hypothalamo-Hypophyseal System; Interleukin-10; Lipopolysaccharides; Mifepristone; Periodontitis; Pituitary-Adrenal System; Placebos; Radiography; Random Allocation; Rats; Receptors, Glucocorticoid; Streptozocin; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha	2014

Article

Year

Chronic treatment with the glucocorticoid receptor antagonist RU486 inhibits diabetes-induced enhancement of experimental periodontitis.

Journal of periodontal research, 2014, Volume: 49, Issue:1

Topics: Alveolar Bone Loss; Animals; Blood Glucose; Body Weight; Corticosterone; Diabetes Mellitus, Experimental; Drug Implants; Escherichia coli; Hormone Antagonists; Hypothalamo-Hypophyseal System; Interleukin-10; Lipopolysaccharides; Mifepristone; Periodontitis; Pituitary-Adrenal System; Placebos; Radiography; Random Allocation; Rats; Receptors, Glucocorticoid; Streptozocin; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha

2014